Entrada Therapeutics Inc. has granted a total of 40,650 restricted stock units (RSUs) and options to purchase 38,850 shares of its common stock to five newly-hired non-executive employees under the 2025 Inducement Equity Plan. The stock options have an exercise price of $9.91 per share, matching the closing price on December 1, 2025. For each employee, one-fourth of the stock options will vest on the one-year anniversary of the vesting commencement date, with the remaining 75% vesting in equal monthly installments over the next three years. Similarly, one-fourth of the RSUs will vest after one year, with 6.25% vesting quarterly thereafter. Vesting is contingent on continued employment or service with the company.